| Year |
Title |
Altmetric |
| 2022
|
Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation study.
Molecular Genetics and Metabolism Reports.
31.
2022
|
|
| 2021
|
A new approach to identifying patients with elevated risk for Fabry disease using a machine learning algorithm.
Orphanet Journal of Rare Diseases.
16.
2021
|
|
| 2021
|
Comparison of Static and Dynamic Baseline Creatinine Surrogates for Defining Acute Kidney Injury
2021
|
|
| 2021
|
Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus.
Molecular Genetics and Metabolism.
132:234-243.
2021
|
|
| 2021
|
Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry disease.
Journal of Medical Genetics.
2021
|
|
| 2020
|
Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: Findings from the opinion-based PREDICT-FD modified Delphi consensus initiative.
BMJ Open.
10.
2020
|
|
| 2020
|
Use of a rare disease registry for establishing phenotypic classification of previously unassigned GLA variants: A consensus classification system by a multispecialty Fabry disease genotype-phenotype workgroup.
Journal of Medical Genetics.
57:542-551.
2020
|
|
| 2020
|
Clinical Trials during the SARS-CoV-2 Pandemic
2020
|
|
| 2020
|
Current and Investigational Therapeutics for Fabry Disease.
Kidney International Reports.
5:407-413.
2020
|
|
| 2020
|
Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease.
Journal of Medical Genetics.
57:38-47.
2020
|
|
| 2019
|
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.
Kidney International.
96:1030-1036.
2019
|
|
| 2019
|
Effects of Bardoxolone Methyl on Magnesium in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease.
CardioRenal Medicine.
9:316-325.
2019
|
|
| 2019
|
JC viruria is associated with reduced risk of diabetic kidney disease.
Journal of Clinical Endocrinology and Metabolism.
104:2286-2294.
2019
|
|
| 2019
|
Cardiovascular outcome trials in patients with chronic kidney disease: Challenges associated with selection of patients and endpoints.
European Heart Journal.
40:880-886.
2019
|
|
| 2019
|
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.
American Journal of Kidney Diseases.
73:206-217.
2019
|
|
| 2018
|
Serum albumin concentration and risk of end-stage renal disease: The REGARDS study.
Nephrology Dialysis Transplantation.
33:1770-1777.
2018
|
|
| 2018
|
Urinary Tubular Injury Biomarkers Are Associated With ESRD and Death in the REGARDS Study.
Kidney International Reports.
3:1183-1192.
2018
|
|
| 2018
|
Blood pressure and metabolic effects of acetyl-L-carnitine in type 2 diabetes: DIABASI randomized controlled trial.
Journal of the Endocrine Society.
2:420-436.
2018
|
|
| 2018
|
Dietary Oxidative Balance Scores and Biomarkers of Inflammation among Individuals with and without Chronic Kidney Disease.
Nephron Extra.
8:11-23.
2018
|
|
| 2018
|
Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.
American Journal of Nephrology.
47:40-47.
2018
|
|
| 2018
|
Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery.
Journal of the American Society of Nephrology.
29:260-267.
2018
|
|
| 2018
|
Conjunctival lymphangiectasia associated with classic Fabry disease.
British Journal of Ophthalmology.
102:54-58.
2018
|
|
| 2017
|
Evaluation of Renal Function and Renal Risk in the Twenty-First Century
2017
|
|
| 2017
|
Global cardiovascular and renal outcomes of reduced GFR.
Journal of the American Society of Nephrology.
28:2167-2179.
2017
|
|
| 2017
|
Risks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria
2017
|
|
| 2017
|
The pressing need for real-time risk assessment of hospital-acquired acute kidney injury.
Nephrology Dialysis Transplantation.
32:766-770.
2017
|
|
| 2017
|
The Fault Is Not in Our Stars but May Be in Our Embryos: Glomerular Number in Low Birth Weight Babies
2017
|
|
| 2017
|
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Kidney International.
91:284-293.
2017
|
|
| 2017
|
The global burden of chronic kidney disease: Estimates, variability and pitfalls.
Nature Reviews Nephrology.
13:104-114.
2017
|
|
| 2016
|
Urinary podocyte loss is increased in patients with fabry disease and correlates with clinical severity of fabry nephropathy.
PLoS One.
11.
2016
|
|
| 2016
|
Serum Creatinine Trajectories for Community- versus Hospital-Acquired Acute Kidney Injury
2016
|
|
| 2016
|
Epilogue: UAB Symposium November 2015
2016
|
|
| 2016
|
Estimated Glomerular Filtration Rate: Fit for What Purpose?
2016
|
|
| 2016
|
Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry.
Molecular Genetics and Metabolism.
119:151-159.
2016
|
|
| 2016
|
Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults.
Stroke.
47:2017-2024.
2016
|
|
| 2016
|
Significant improvement in Fabry disease podocytopathy after 3 years of treatment with agalsidase beta.
Pediatric Nephrology.
31:1369-1373.
2016
|
|
| 2016
|
Competing risks: you only die once.
Nephrology Dialysis Transplantation.
31:1033-1035.
2016
|
|
| 2016
|
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: Data from the Fabry Registry.
Journal of Medical Genetics.
53:495-502.
2016
|
|
| 2016
|
Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration.
Kidney International.
89:354-362.
2016
|
|
| 2016
|
Sulfenic acid modification of endothelin b receptor is responsible for the benefit of a nonsteroidal mineralocorticoid receptor antagonist in renal ischemia.
Journal of the American Society of Nephrology.
27:398-404.
2016
|
|
| 2016
|
The role of cystatin-C in the confirmation of reduced glomerular filtration rate among the oldest old.
Archives of Medical Science.
12:55-67.
2016
|
|
| 2016
|
Association of reduced eGFR and albuminuria with serious fall injuries among older adults.
Clinical Journal of the American Society of Nephrology.
11:1236-1243.
2016
|
|
| 2016
|
Categories of hospital-associated acute kidney injury: Time course of changes in serum creatinine values
2016
|
|
| 2016
|
Gastrointestinal involvement in Fabry disease: So important, yet often neglected
2016
|
|
| 2016
|
Past decline versus current EGFR and subsequent mortality risk.
Journal of the American Society of Nephrology.
27:2456-2466.
2016
|
|
| 2016
|
Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.
American Journal of Kidney Diseases.
67:62-69.
2016
|
|
| 2015
|
A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury.
American Journal of Kidney Diseases.
66:602-612.
2015
|
|
| 2015
|
Amiloride: The “new” renal tonic?
2015
|
|
| 2015
|
Validation of an albuminuria self-assessment tool in the Multi-Ethnic Study of Atherosclerosis (MESA)
2015
|
|
| 2015
|
Oral migalastat HCl leads to greater systemic exposure and tissue levels of active α-galactosidase A in fabry patients when co-administered with infused agalsidase.
PLoS One.
10.
2015
|
|
| 2015
|
Appendiceal tissue confirmation of Fabry's disease.
Kidney International.
88:417.
2015
|
|
| 2015
|
The furosemide stress test and predicting AKI outcomes.
Journal of the American Society of Nephrology.
26:1762-1764.
2015
|
|
| 2015
|
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: A collaborative meta-analysis of individual participant data.
Lancet Diabetes and Endocrinology.
3:514-525.
2015
|
|
| 2015
|
Oral anticoagulants and risk of nephropathy.
Drug Safety.
38:527-533.
2015
|
|
| 2015
|
Rapid immunochromatographic detection of serum anti-α-Galactosidase a antibodies in fabry patients after enzyme replacement therapy.
PLoS One.
10.
2015
|
|
| 2015
|
Late onset variants in Fabry disease: Results in high risk population screenings in Argentina.
Molecular Genetics and Metabolism Reports.
4:19-24.
2015
|
|
| 2015
|
Obesity, metabolic health, and the risk of end-stage renal disease.
Kidney International.
87:1216-1222.
2015
|
|
| 2015
|
Contrasting cholesterol management guidelines for adults with CKD.
Journal of the American Society of Nephrology.
26:1173-1180.
2015
|
|
| 2015
|
Validation study of medicare claims to identify older US adults with CKD using the reasons for geographic and racial differences in stroke (REGARDS) study.
American Journal of Kidney Diseases.
65:249-258.
2015
|
|
| 2015
|
Antiproteinuric therapy and Fabry nephropathy: Factors associated with preserved kidney function during agalsidase-beta therapy.
Journal of Medical Genetics.
52:860-866.
2015
|
|
| 2015
|
Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial.
Circulation.
132:27-39.
2015
|
|
| 2015
|
Cognitive function in adults aging with fabry disease: A case–control feasibility study using telephone-based assessments.
JIMD Reports.
18:41-50.
2015
|
|
| 2015
|
Foot process effacement is an early marker of nephropathy in young classic fabry patients without albuminuria
2015
|
|
| 2015
|
Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with fabry disease.
Journal of Medical Genetics.
52:353-358.
2015
|
|
| 2015
|
The effects of cinacalcet in older and younger patients on hemodialysis: The evaluation of cinacalcet HCL therapy to lower cardiovascular events (EVOLVE) trial.
Clinical Journal of the American Society of Nephrology.
10:791-799.
2015
|
|
| 2014
|
Pathophysiology and Treatment of Resistant Hypertension: The Role of Aldosterone and Amiloride-Sensitive Sodium Channels.
Seminars in Nephrology.
34:532-539.
2014
|
|
| 2014
|
Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry.
Clinica Chimica Acta.
438:195-204.
2014
|
|
| 2014
|
Meta-Analysis of Genome-Wide Association Studies in African Americans Provides Insights into the Genetic Architecture of Type 2 Diabetes.
PLoS Genetics.
10.
2014
|
|
| 2014
|
Acute hyperkalemia associated with inhalation of a potent ENaC antagonist: Phase 1 trial of GS-9411.
Journal of Aerosol Medicine and Pulmonary Drug Delivery.
27:200-208.
2014
|
|
| 2014
|
Fabry disease: Dose matters.
Journal of the American Society of Nephrology.
25:653-655.
2014
|
|
| 2014
|
Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice.
Acta Neuropathologica Communications.
2.
2014
|
|
| 2014
|
Association of inflammatory and endothelial cell activation biomarkers with acute kidney injury after sepsis.
SpringerPlus.
3:1-8.
2014
|
|
| 2014
|
Blood pressure and amiloride-sensitive sodium channels in vascular and renal cells..
Nature Reviews Nephrology.
10:146-157.
2014
|
|
| 2014
|
Dietary patterns and risk of death and progression to ESRD in individuals with CKD: A cohort study.
American Journal of Kidney Diseases.
64:204-213.
2014
|
|
| 2014
|
Incident ESRD and treatment-resistant hypertension: The reasons for geographic and racial differences in stroke (REGARDS) study.
American Journal of Kidney Diseases.
63:781-788.
2014
|
|
| 2014
|
Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.
American Journal of Nephrology.
39:499-508.
2014
|
|
| 2014
|
Nondisease-specific problems and all-cause mortality among older adults with CKD: The REGARDS study.
Clinical Journal of the American Society of Nephrology.
9:1737-1745.
2014
|
|
| 2014
|
Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar.
Kidney International.
86:819-827.
2014
|
|
| 2014
|
Similar names for similar biologics
2014
|
|
| 2013
|
Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD.
Clinical Journal of the American Society of Nephrology.
8:2064-2071.
2013
|
|
| 2013
|
Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: Data from the Fabry Registry.
Genetics in Medicine.
15:958-965.
2013
|
|
| 2013
|
Prevalence of apparent treatment-resistant hypertension among individuals with CKD.
Clinical Journal of the American Society of Nephrology.
8:1583-1590.
2013
|
|
| 2013
|
Association between urinary albumin excretion and coronary heart disease in black vs white adults.
Journal of the American Medical Association.
310:706-713.
2013
|
|
| 2013
|
Fibrosis: A key feature of Fabry disease with potential therapeutic implications.
Orphanet Journal of Rare Diseases.
8.
2013
|
|
| 2013
|
High-Sensitivity C-Reactive Protein and Risk of Sepsis.
PLoS One.
8.
2013
|
|
| 2013
|
Pharmacovigilance and biosimilars: Considerations, needs and challenges.
Expert Opinion on Biological Therapy.
13:1039-1047.
2013
|
|
| 2013
|
Cardiovascular risk factors in CKD associate with both ESRD and mortality.
Journal of the American Society of Nephrology.
24:1159-1165.
2013
|
|
| 2013
|
Comparison of absolute serum creatinine changes versus Kidney Disease: Improving Global Outcomes consensus definitions for characterizing stages of acute kidney injury.
Nephrology Dialysis Transplantation.
28:1447-1454.
2013
|
|
| 2013
|
Genetic disorders of potassium homeostasis.
Seminars in Nephrology.
33:300-309.
2013
|
|
| 2013
|
The amiloride-sensitive endothelial sodium channel and vascular tone.
Hypertension.
61:952-954.
2013
|
|
| 2013
|
Association of duration of residence in the southeastern United States with chronic kidney disease may differ by race: The REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study.
International Journal of Health Geographics.
12.
2013
|
|
| 2013
|
Geographic variation in CKD prevalence and ESRD incidence in the united states: Results from the reasons for geographic and racial differences in stroke (REGARDS) study.
American Journal of Kidney Diseases.
61:395-403.
2013
|
|
| 2013
|
Healthy behaviors, risk factor control and awareness of chronic kidney disease.
American Journal of Nephrology.
37:135-143.
2013
|
|
| 2013
|
Low hemoglobin levels and recurrent falls in U.S. Men and Women: Prospective findings from the REasons for Geographic and racial differences in stroke (REGARDS) cohort.
American Journal of the Medical Sciences.
345:446-454.
2013
|
|
| 2013
|
Rationale and trial design of bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes: The occurrence of renal events (BEACON).
American Journal of Nephrology.
37:212-222.
2013
|
|
| 2013
|
Risk for recurrent coronary heart disease and all-cause mortality among individuals with chronic kidney disease compared with diabetes mellitus, metabolic syndrome, and cigarette smokers.
American Heart Journal.
166.
2013
|
|
| 2012
|
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
New England Journal of Medicine.
367:2482-2494.
2012
|
|
| 2012
|
Arrhythmias in Fabry cardiomyopathy
2012
|
|
| 2012
|
Low income and albuminuria among REGARDS (Reasons for geographic and racial differences in stroke) study participants.
American Journal of Kidney Diseases.
60:779-786.
2012
|
|
| 2012
|
Racial differences in albuminuria, kidney function, and risk of stroke.
Neurology.
79:1686-1692.
2012
|
|
| 2012
|
Prevalence and prognosis of unrecognized myocardial infarctions in chronic kidney disease.
Nephrology Dialysis Transplantation.
27:3482-3488.
2012
|
|
| 2012
|
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease.
American Journal of Hypertension.
25:789-796.
2012
|
|
| 2012
|
Critical care nephrology: Management of acid-base disorders with CRRT.
Kidney International.
82:9-18.
2012
|
|
| 2012
|
Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end- stage renal disease and peritoneal dialysis.
Contributions to Nephrology.
178:157-163.
2012
|
|
| 2012
|
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.
Journal of the American Medical Association.
307:1941-1951.
2012
|
|
| 2012
|
Cardiomyopathy and response to enzyme replacement therapy in a male mouse model for fabry disease.
PLoS One.
7.
2012
|
|
| 2012
|
Acute kidney injury and mortality in hospitalized patients.
American Journal of Nephrology.
35:349-355.
2012
|
|
| 2012
|
Design of clinical trials in AKI: A report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings.
Clinical Journal of the American Society of Nephrology.
7:856-860.
2012
|
|
| 2012
|
Design of clinical trials in acute kidney injury: A report from an NIDDK workshop-prevention trials.
Clinical Journal of the American Society of Nephrology.
7:851-855.
2012
|
|
| 2012
|
Design of clinical trials in acute kidney injury: Report from an NIDDK workshop on trial methodology.
Clinical Journal of the American Society of Nephrology.
7:844-850.
2012
|
|
| 2012
|
Anti-α-galactosidase A antibody response to agalsidase beta treatment: Data from the Fabry Registry.
Molecular Genetics and Metabolism.
105:443-449.
2012
|
|
| 2012
|
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation..
Nephrology Dialysis Transplantation.
27:1042-1049.
2012
|
|
| 2012
|
Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident esrd.
American Journal of Kidney Diseases.
59:25-31.
2012
|
|
| 2012
|
Incidence of stroke symptoms among adults with chronic kidney disease: Results from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
Nephrology Dialysis Transplantation.
27:166-173.
2012
|
|
| 2012
|
Renal outcomes of agalsidase beta treatment for Fabry disease: Role of proteinuria and timing of treatment initiation.
Nephrology Dialysis Transplantation.
27:1042-1049.
2012
|
|
| 2011
|
Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications.
Clinical Journal of the American Society of Nephrology.
6:2822-2828.
2011
|
|
| 2011
|
The authors reply.
New England Journal of Medicine.
365:1746-1747.
2011
|
|
| 2011
|
Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States.
American Journal of Kidney Diseases.
58:756-763.
2011
|
|
| 2011
|
Chronic kidney disease and risk of death from infection.
American Journal of Nephrology.
34:330-336.
2011
|
|
| 2011
|
Age-specific association of reduced estimated glomerular filtration rate and albuminuria with all-cause mortality.
Clinical Journal of the American Society of Nephrology.
6:2200-2207.
2011
|
|
| 2011
|
Albuminuria and racial disparities in the risk for ESRD.
Journal of the American Society of Nephrology.
22:1721-1728.
2011
|
|
| 2011
|
Membranous glomerulopathy in an adult patient with X-linked agammaglobulinemia receiving intravenous gammaglobulin
2011
|
|
| 2011
|
Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) study.
American Journal of Kidney Diseases.
58:177-185.
2011
|
|
| 2011
|
Development and validation of a self-assessment tool for albuminuria: Results from the reasons for geographic and racial differences in stroke (REGARDS) study.
American Journal of Kidney Diseases.
58:196-205.
2011
|
|
| 2011
|
Inflammation biomarkers and risk of all-cause mortality in the reasons for geographic and racial differences in stroke cohort.
American Journal of Epidemiology.
174:284-292.
2011
|
|
| 2011
|
Bardoxolone methyl and kidney function in CKD with type 2 diabetes.
New England Journal of Medicine.
365:327-336.
2011
|
|
| 2011
|
Warfarin-related nephropathy: Another newly recognized complication of an old drug.
Kidney International.
80:131-133.
2011
|
|
| 2011
|
A distinct urinary biomarker pattern characteristic of female fabry patients that mirrors response to enzyme replacement therapy.
PLoS One.
6.
2011
|
|
| 2011
|
Effect of bardoxolone methyl on kidney function in patients with T2D and stage 3b-4 CKD.
American Journal of Nephrology.
33:469-476.
2011
|
|
| 2011
|
Vitamin D receptor activation: Implications for daily practice.
Contributions to Nephrology.
171:172-180.
2011
|
|
| 2011
|
Detection of chronic kidney disease with creatinine, cystatin c, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.
Journal of the American Medical Association.
305:1545-1552.
2011
|
|
| 2011
|
The fabry cardiomyopathy: Models for the cardiologist.
Annual Review of Medicine.
62:59-67.
2011
|
|
| 2011
|
Association of chronic kidney disease with atrial fibrillation among adults in the United States REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
Circulation: Arrhythmia and Electrophysiology.
4:26-32.
2011
|
|
| 2011
|
Mineralocorticoid receptor activation and blockade: An emerging paradigm in chronic kidney disease.
Kidney International.
79:1051-1060.
2011
|
|
| 2010
|
How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?.
Clinica Chimica Acta.
411:1906-1914.
2010
|
|
| 2010
|
Hemoglobin concentration and cognitive impairment in the renal REasons for Geographic And Racial Differences in Stroke (REGARDS) study
2010
|
|
| 2010
|
Prognostic indicators of renal disease progression in adults with fabry disease: Natural history data from the Fabry Registry.
Clinical Journal of the American Society of Nephrology.
5:2220-2228.
2010
|
|
| 2010
|
Blood pressure, proteinuria and nephropathy in Fabry disease
2010
|
|
| 2010
|
Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study.
American Journal of Kidney Diseases.
56:861-871.
2010
|
|
| 2010
|
Associations of dietary fat with albuminuria and kidney dysfunction.
American Journal of Clinical Nutrition.
92:897-904.
2010
|
|
| 2010
|
Introduction to the Third Annual Rostand Vitamin D Symposium.
Clinical Journal of the American Society of Nephrology.
5:1696.
2010
|
|
| 2010
|
The natural history of fabry disease
2010
|
|
| 2010
|
Poverty and racial disparities in kidney disease: The REGARDS study.
American Journal of Nephrology.
32:38-46.
2010
|
|
| 2010
|
A roadmap for biomarker qualification.
Nature Biotechnology.
28:444-445.
2010
|
|
| 2010
|
Physical and psychological burden of chronic kidney disease among older adults.
American Journal of Nephrology.
31:309-317.
2010
|
|
| 2010
|
Enzyme replacement therapy and fabry nephropathy.
Clinical Journal of the American Society of Nephrology.
5:371-378.
2010
|
|
| 2010
|
Introduction to focus on Fabry nephropathy: Biomarkers, progression, and disease severity.
Clinical Journal of the American Society of Nephrology.
5:359.
2010
|
|
| 2010
|
A validated disease severity scoring system for Fabry disease.
Molecular Genetics and Metabolism.
99:283-290.
2010
|
|
| 2010
|
End-stage renal disease in patients with Fabry disease: Natural history data from the Fabry Registry.
Nephrology Dialysis Transplantation.
25:769-775.
2010
|
|
| 2010
|
Acute kidney injury in sepsis: Questions answered, but others remain.
Kidney International.
77:485-487.
2010
|
|
| 2010
|
Acute kidney injury: Where's the consensus about its definition.
Nephrology Dialysis Transplantation.
25:9-11.
2010
|
|
| 2010
|
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010
|
|
| 2010
|
Enzyme replacement therapy for Fabry's disease
2010
|
|
| 2010
|
QT prolongation is an independent predictor of mortality in end-stage renal disease
2010
|
|
| 2010
|
Scoring system for renal pathology in Fabry disease: Report of the International Study Group of Fabry Nephropathy (ISGFN).
Nephrology Dialysis Transplantation.
25:2168-2177.
2010
|
|
| 2009
|
Mineralocorticoid receptor blockers and chronic kidney disease.
Clinical Journal of the American Society of Nephrology.
4:1685-1691.
2009
|
|
| 2009
|
Exploration of anaemia as a progression factor in African Americans with cardiovascular disease.
Nephrology Dialysis Transplantation.
24:3404-3411.
2009
|
|
| 2009
|
Fabry disease: Progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy.
Nephrology Dialysis Transplantation.
24:2102-2111.
2009
|
|
| 2009
|
Nephropathy in Fabry disease: The importance of early diagnosis and testing in high-risk populations.
Nephrology Dialysis Transplantation.
24:1736-1743.
2009
|
|
| 2009
|
Correlates of anemia in American Blacks and Whites: The REGARDS Renal Ancillary study.
American Journal of Epidemiology.
169:355-364.
2009
|
|
| 2009
|
The A563T variation of the renal epithelial calcium channel TRPV5 among African Americans enhances calcium influx
2009
|
|
| 2008
|
Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease.
Biologics: Targets and Therapy.
2:823-843.
2008
|
|
| 2008
|
Chronic kidney disease is often unrecognized among patients with coronary heart disease: The REGARDS cohort study.
American Journal of Nephrology.
29:10-17.
2008
|
|
| 2008
|
Introduction to vitamin D symposium, March 14, 2008.
Clinical Journal of the American Society of Nephrology.
3:1534.
2008
|
|
| 2008
|
Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
American Journal of Kidney Diseases.
52:227-234.
2008
|
|
| 2008
|
Racial Differences in the Competing Risks of Mortality and ESRD After Acute Myocardial Infarction.
American Journal of Kidney Diseases.
52:251-261.
2008
|
|
| 2008
|
Authors' response
2008
|
|
| 2008
|
Evaluation and initial management of acute kidney injury.
Clinical Journal of the American Society of Nephrology.
3:962-967.
2008
|
|
| 2008
|
Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.
Nature Reviews Nephrology.
4:327-336.
2008
|
|
| 2008
|
Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified delphi process.
Clinical Journal of the American Society of Nephrology.
3:887-894.
2008
|
|
| 2008
|
Nephropathy in males and females with Fabry disease: Cross-sectional description of patients before treatment with enzyme replacement therapy.
Nephrology Dialysis Transplantation.
23:1600-1607.
2008
|
|
| 2008
|
Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction.
JAMA Internal Medicine.
168:609-616.
2008
|
|
| 2008
|
Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry.
Molecular Genetics and Metabolism.
93:112-128.
2008
|
|
| 2007
|
Enzyme Replacement Therapy and Fabry Kidney Disease
2007
|
|
| 2007
|
Membrane tension modulates the effects of apical cholesterol on the renal epithelial sodium channel
2007
|
|
| 2007
|
Reliability of urinary albumin, total protein, and creatinine assays after prolonged storage: The family investigation of nephropathy and diabetes.
Clinical Journal of the American Society of Nephrology.
2:1156-1162.
2007
|
|
| 2007
|
Improving outcomes from acute kidney injury: Report of an initiative.
Pediatric Nephrology.
22:1655-1658.
2007
|
|
| 2007
|
Predictors of Survival in Patients With End-Stage Renal Disease Evaluated for Kidney Transplantation.
American Journal of Cardiology.
100:1020-1025.
2007
|
|
| 2007
|
An intermediate-conductance Ca2+-activated K+ channel mediates B lymphoma cell cycle progression induced by serum
2007
|
|
| 2007
|
Antiproteinuric therapy and fabry nephropathy: Sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-β.
Journal of the American Society of Nephrology.
18:2609-2617.
2007
|
|
| 2007
|
Improving outcomes of acute kidney injury: Report of an initiative.
Nature Reviews Nephrology.
3:439-442.
2007
|
|
| 2007
|
Improving Outcomes From Acute Kidney Injury: Report of an Initiative.
American Journal of Kidney Diseases.
50:1-4.
2007
|
|
| 2007
|
Improving outcomes from acute kidney injury.
Journal of the American Society of Nephrology.
18:1992-1994.
2007
|
|
| 2007
|
Enzyme replacement therapy and fabry kidney disease: Quo vadis?.
Journal of the American Society of Nephrology.
18:1368-1370.
2007
|
|
| 2007
|
Prevalence and characteristics of a family history of end-stage renal disease among adults in the United States population: Reasons for Geographic and Racial Differences in Stroke (REGARDS) renal cohort study.
Journal of the American Society of Nephrology.
18:1344-1352.
2007
|
|
| 2007
|
Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury
2007
|
|
| 2007
|
Agalsidase-beta therapy for advanced fabry disease: A randomized trial.
ACP journal club.
146:77-86.
2007
|
|
| 2007
|
Improving outcomes from acute kidney injury (AKI): Report on an initiative.
International Journal of Artificial Organs.
30:373-376.
2007
|
|
| 2007
|
WNK4-mediated regulation of renal ion transport proteins
2007
|
|
| 2006
|
Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement.
Genetics in Medicine.
8:539-548.
2006
|
|
| 2006
|
Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study.
Journal of the American Society of Nephrology.
17:1710-1715.
2006
|
|
| 2006
|
Chronic kidney disease: a public health problem that needs a public health action plan.
2006
|
|
| 2006
|
Recent progress in inherited kidney diseases.
Advances in Chronic Kidney Disease.
13:95.
2006
|
|
| 2006
|
Drug insight: Safety of intravenous iron supplementation with sodium ferric gluconate complex.
Nature Reviews Nephrology.
2:92-100.
2006
|
|
| 2006
|
Chronic kidney disease: A public health problem that needs a public health action plan
2006
|
|
| 2006
|
Diagnosis and management of kidney involvement in fabry disease.
Advances in Chronic Kidney Disease.
13:138-147.
2006
|
|
| 2006
|
Survival advantage of black patients with kidney disease after acute myocardial infarction..
Clinical Journal of the American Society of Nephrology.
1:993-999.
2006
|
|
| 2006
|
Synergistic protective effects of erythropoietin and olmesartan on ischemic stroke survival and post-stroke memory dysfunctions in the gerbil.
Journal of Hypertension.
24:2255-2261.
2006
|
|
| 2005
|
Renal sodium handling: The role of the epithelial sodium channel.
Journal of the American Society of Nephrology.
16:3151-3153.
2005
|
|
| 2005
|
Time-dependent associations between iron and mortality in hemodialysis patients.
Journal of the American Society of Nephrology.
16:3070-3080.
2005
|
|
| 2005
|
Towards a definition and classification of acute kidney injury.
Journal of the American Society of Nephrology.
16:3149-3150.
2005
|
|
| 2005
|
Delay in time to receipt of thrombolytic medication among medicare patients with kidney disease.
American Journal of Kidney Diseases.
46:595-602.
2005
|
|
| 2005
|
K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease: Work group membership.
American Journal of Kidney Diseases.
46.
2005
|
|
| 2005
|
Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study: Baseline results.
Kidney International.
68:1427-1431.
2005
|
|
| 2005
|
Improvement of blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension.
Hypertension.
46:469-470.
2005
|
|
| 2005
|
Hypertension: A companion to brenner and rector's the kidney.
Seminars in Nephrology.
1-872.
2005
|
|
| 2005
|
Fabry disease: Diagnosis and management, with emphasis on the renal manifestations.
Current Opinion in Nephrology and Hypertension.
14:87-95.
2005
|
|
| 2005
|
Importance of Proteinuria and Its Treatment in Patients with Fabry Disease Receiving Enzyme Replacement Therapy.
Nihon Jinzo Gakkai shi.
47:220-221.
2005
|
|
| 2005
|
Importance of Proteinuria and Its Treatment in Patients with Fabry Disease Receiving Enzyme Replacement Therapy.
Nihon Jinzo Gakkai shi.
47:221-223.
2005
|
|
| 2004
|
Hyperkalemia after the Publication of RALES [1] (multiple letters).
New England Journal of Medicine.
351:2448-2450.
2004
|
|
| 2004
|
Vascular grafts for hemodialysis: Types, sites and techniques.
Contributions to Nephrology.
142:73-93.
2004
|
|
| 2004
|
Inclusion of albumin as a target in therapy guidelines: Guidelines for chronic kidney disease.
Kidney international. Supplement.
66.
2004
|
|
| 2004
|
Acidic ATP activates lymphocyte outwardly rectifying chloride channels via a novel pathway
2004
|
|
| 2004
|
Steroids and exogenous γ-ENaC subunit modulate cation channels formed by α-ENaC in human B lymphocytes.
Journal of Biological Chemistry.
279:33206-33212.
2004
|
|
| 2004
|
Sodium ferric gluconate complex in haemodialysis patients: A prospective evaluation of long-term safety.
Nephrology Dialysis Transplantation.
19:1576-1580.
2004
|
|
| 2004
|
Hypertension..
American Journal of Kidney Diseases.
44:369-375.
2004
|
|
| 2004
|
Oxidative Stress in Hypertension and Chronic Kidney Disease: Role of Angiotensin II.
Seminars in Nephrology.
24:101-114.
2004
|
|
| 2004
|
Sodium and potassium handling by the aldosterone-sensitive distal nephron: The pivotal role of the distal and connecting tubule
2004
|
|
| 2003
|
WNK kinases, distal tubular ion handling and hypertension.
Nephrology Dialysis Transplantation.
18:2463-2467.
2003
|
|
| 2003
|
Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport.
Hypertension.
42:195-199.
2003
|
|
| 2003
|
Interventional nephrology: Work in progress.
American Journal of Kidney Diseases.
42:388-391.
2003
|
|
| 2003
|
Familial hyperkalemic hypertension: Phenotypic analysis in a large family with the WNK1 deletion mutation.
American Journal of Medicine.
114:495-498.
2003
|
|
| 2003
|
Chronic use of sodium ferric gluconate complex in hemodialysis patients: Safety of higher-dose (≥250 mg) administration.
American Journal of Kidney Diseases.
41:651-657.
2003
|
|
| 2003
|
Hereditary disorders of potassium homeostasis
2003
|
|
| 2003
|
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.
American Journal of Medicine.
115:291-297.
2003
|
|
| 2003
|
Sodium ferric gluconate complex in hemodialysis patients. Ii. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients.
Kidney International.
63:217-224.
2003
|
|
| 2002
|
Epithelial sodium channels expressed in Xenopus oocytes are activated by cyclic-AMP.
Clinical and Experimental Nephrology.
6:195-201.
2002
|
|
| 2002
|
Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT1 receptors.
Journal of the American Society of Nephrology.
13:1131-1135.
2002
|
|
| 2002
|
Renal genetic disorders related to K+ and Mg2+.
Annual Review of Physiology.
64:845-876.
2002
|
|
| 2002
|
Anionic phospholipids regulate native and expressed epithelial sodium channel (ENaC).
Journal of Biological Chemistry.
277:7641-7644.
2002
|
|
| 2002
|
Genetic forms of renal potassium and magnesium wasting.
American Journal of Medicine.
112:235-236.
2002
|
|
| 2002
|
ATP masks stretch activation of epithelial sodium channels in A6 distal nephron cells
2002
|
|
| 2002
|
Issues related to iron replacement in chronic kidney disease.
Seminars in Nephrology.
22:479-487.
2002
|
|
| 2002
|
Sodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextran.
Kidney International.
61:1830-1839.
2002
|
|
| 2001
|
Liddle's syndrome: Genetics and mechanisms of Na+ channel defects.
Contributions to Nephrology.
136:1-10.
2001
|
|
| 2001
|
Genetic forms of human hypertension.
Current Opinion in Nephrology and Hypertension.
10:493-499.
2001
|
|
| 2001
|
An Alu cassette in the human epithelial sodium channel
2001
|
|
| 2001
|
Genetic renal tubular disorders of renal ion channels and transporters.
Seminars in Nephrology.
21:81-93.
2001
|
|
| 2001
|
Liddle syndrome: Genetics and mechanisms of Na+ channel defects.
American Journal of the Medical Sciences.
322:302-307.
2001
|
|
| 2001
|
Localization and functional characterization of NA+/H+ exchanger isoform NHE4 in rat thick ascending limbs
2001
|
|
| 2001
|
Nitric oxide and Bartter and Gitelman syndromes.
Kidney International.
60:1197-1198.
2001
|
|
| 2001
|
Prevention, protection, and the intrarenal renin-angiotensin systems.
Seminars in Nephrology.
21:593-602.
2001
|
|
| 2001
|
Simplified citrate anticoagulation for continuous renal replacement therapy.
Kidney International.
60:370-374.
2001
|
|
| 2000
|
Disorders of the epithelial Na+ channel in Liddle's syndrome and autosomal recessive pseudohypoaldosteronism type 1
2000
|
|
| 2000
|
Interaction of syntaxins with epithelial ion channels.
Current Opinion in Nephrology and Hypertension.
9:523-527.
2000
|
|
| 2000
|
Low renin hypertension in the next millennium.
Seminars in Nephrology.
20:40-46.
2000
|
|
| 2000
|
Aldosterone-related genetic effects in hypertension.
Current Hypertension Reports.
2:295-301.
2000
|
|
| 2000
|
Macula densa Na+/H+ exchange activities mediated by apical NHE2 and basolateral NHE4 isoforms
2000
|
|
| 1999
|
Interaction of syntaxins with the amiloride-sensitive epithelial sodium channel.
Journal of Biological Chemistry.
274:20812-80817.
1999
|
|
| 1999
|
Mechanisms of Disease: Genetic disorders of renal electrolyte transport.
New England Journal of Medicine.
340:1177-1187.
1999
|
|
| 1999
|
Accessory factors and the regulation of epithelial sodium channel activity.
Journal of Clinical Investigation.
103:593.
1999
|
|
| 1999
|
Expression of transfected human Na+/H+ exchanger (NHE-1) in the basolateral membrane of opossum kidney cells.
Journal of Cellular Physiology.
178:44-50.
1999
|
|
| 1999
|
Low-renin and nonmodulating essential hypertension.
Hypertension.
34:395-397.
1999
|
|
| 1999
|
Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure.
Kidney International.
55:2423-2432.
1999
|
|
| 1999
|
Regulation by PKC isoforms of Na+/H+ exchanger in luminal membrane vesicles isolated from cortical tubules
1999
|
|
| 1999
|
Regulation of endosomal acidification via G1-type protein.
Kidney International.
55:2524-2525.
1999
|
|
| 1999
|
T594M mutation in the ENaC β subunit and low-renin hypertension in blacks.
American Journal of Kidney Diseases.
34:579-583.
1999
|
|
| 1999
|
The epithelial sodium channel in hypertension.
Current Hypertension Reports.
1:158-163.
1999
|
|
| 1999
|
αENaC: Leading the charge.
Journal of Clinical Investigation.
104:849-850.
1999
|
|
| 1998
|
Cloning and functional studies of splice variants of the α-subunit of the amiloride-sensitive Na+ channel
1998
|
|
| 1998
|
Immunolocalization of the Na+/H+ exchanger isoform NHE2 in rat kidney
1998
|
|
| 1998
|
Inverse relationship of urinary cyclic GMP to blood pressure reactivity in the CARDIA study: Vasodilatory regulation of sympathetic vasoconstriction.
Psychosomatic Medicine.
60:319-326.
1998
|
|
| 1998
|
Liddie syndrome: An autosomal dominant form of human hypertension.
Kidney International.
53:18-24.
1998
|
|
| 1997
|
Evidence for an amiloride-insensitive Na+/H+ exchanger in rat renal cortical tubules.
American Journal of Physiology.
273.
1997
|
|
| 1997
|
The human angiotensinase C gene (HUMPCP) maps to 11q14 within 700 kb of D11S901: A candidate gene for essential hypertension.
Genomics.
44:365-367.
1997
|
|
| 1997
|
Acute renal failure in the 21st century: Recommendations for management and outcomes assessment.
American Journal of Kidney Diseases.
29:793-799.
1997
|
|
| 1997
|
Evidence for an amiloride-insensitive Na+/H+ exchanger in rat renal cortical tubules
1997
|
|
| 1997
|
Expression of the amiloride-sensitive sodium channel β subunit gene in human B lymphocytes.
Journal of the American Society of Nephrology.
8:126-129.
1997
|
|
| 1997
|
Heterologous expression of rat NHE4: A highly amiloride-resistant Na+/H+ exchanger isoform
1997
|
|
| 1997
|
Relationship of diastolic blood pressure with cyclic GMP excretion among young adults (the CARDIA study): Influence of a family history of hypertension.
Journal of Hypertension.
15:955-962.
1997
|
|
| 1997
|
Sodium transporters in health and disease.
Current Opinion in Nephrology and Hypertension.
6:372-376.
1997
|
|
| 1996
|
Polymorphism in the beta subunit and Na+ transport.
Journal of the American Society of Nephrology.
7:2490-2494.
1996
|
|
| 1996
|
Biophysical properties of amiloride-sensitive sodium channels (ASSC) in human B lymphocytes.
Journal of Investigative Medicine.
44.
1996
|
|
| 1996
|
Genetic association of 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks.
Hypertension.
28:478-482.
1996
|
|
| 1996
|
Isolation and characterization of luminal and basolateral plasma membrane vesicles from the medullary thick ascending loop of Henle.
Kidney International.
50:1051-1057.
1996
|
|
| 1996
|
Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease.
American Journal of Kidney Diseases.
27:341-346.
1996
|
|
| 1996
|
Liddle's disease: Abnormal regulation of amiloride-sensitive Na+ channels by β-subunit mutation
1996
|
|
| 1996
|
Peptide block of constitutively activated Na+ channels in Liddle's disease
1996
|
|
| 1996
|
Rapid redistribution and inhibition of renal sodium transporters during acute pressure natriuresis.
American Journal of Physiology.
270.
1996
|
|
| 1996
|
Renal Na+/H+ exchanger isoforms and their regulation by thyroid hormone.
American Journal of Physiology.
270.
1996
|
|
| 1996
|
Sticky business: cytoskeleton and Na+ transport..
Journal of Clinical Investigation.
97:2691.
1996
|
|
| 1996
|
Stretch modulates amiloride sensitivity and cation selectivity of sodium channels in human B lymphocytes
1996
|
|
| 1995
|
Cyclosporine inhibits the renal response to L-arginine in human kidney transplant recipients.
Journal of the American Society of Nephrology.
5:1426-1433.
1995
|
|
| 1995
|
Immunopurification and functional reconstitution of a Na+ channel complex from rat lymphocytes
1995
|
|
| 1995
|
Liddle's syndrome: A public health menace?.
American Journal of Kidney Diseases.
25:924-927.
1995
|
|
| 1995
|
Liddle’s syndrome: Heritable human hypertension caused by mutations in the ß subnit of the epithelial sodium channel.
Journal of Endocrinological Investigation.
18:592-594.
1995
|
|
| 1995
|
Mutational analysis of transmembrane histidines in the amiloride-sensitive Na+/H+ exchanger.
American Journal of Physiology.
269.
1995
|
|
| 1994
|
Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel.
Cell.
79:407-414.
1994
|
|
| 1994
|
G-proteins modulate amiloride-sensitive sodium channels.
Journal of Biological Chemistry.
269:17780-17783.
1994
|
|
| 1994
|
Liddle's Syndrome Revisited – A Disorder of Sodium Reabsorption in the Distal Tubule.
New England Journal of Medicine.
330:178-181.
1994
|
|
| 1994
|
Analysis of the genetic contamination of salt-sensitive Dahl/Rapp rats.
Hypertension.
24:255-259.
1994
|
|
| 1994
|
Liddle syndrome: Clinical and cellular abnormalities.
Hospital practice (Office ed.).
29.
1994
|
|
| 1994
|
Renal apical membrane sodium-hydrogen exchange in genetic salt-sensitive hypertension.
Hypertension.
24:491-498.
1994
|
|
| 1993
|
Amiloride-sensitive sodium conductance in human B lymphoid cells.
American Journal of Physiology.
265.
1993
|
|
| 1993
|
Chromosomal Localization of Angiotensin II Type 1 Receptor Isoforms in the Rat.
Biochemical and Biophysical Research Communications.
194:677-682.
1993
|
|
| 1993
|
Amiloride-sensitive sodium conductance in human B lymphoid cells.
American Journal of Physiology.
265.
1993
|
|
| 1993
|
Cytosolic pH sensitivity of an expressed human NHE-1 Na+-H+ exchanger.
American Journal of Physiology.
264.
1993
|
|
| 1993
|
Liddle's syndrome: 30 years later.
Journal of Nephrology.
6:142-148.
1993
|
|
| 1991
|
IgA nephropathy in blacks: Studies of IgA2 allotypes and clinical course.
Kidney International.
39:1218-1224.
1991
|
|
| 1990
|
Mechanism of H+ secretion in the proximal convoluted tubule.
Seminars in Nephrology.
10:93-103.
1990
|
|
| 1989
|
Distinct epitopes on amiloride.
American Journal of Physiology.
257.
1989
|
|
| 1989
|
Accumulation of weak base in gastric mucosa provides evidence for an acidic storage compartment.
American Journal of Physiology.
257.
1989
|
|
| 1989
|
K-Cl cotransport systems.
Kidney International.
36:412-417.
1989
|
|
| 1989
|
Pharmacokinetics of esmolol and ASL-8123 in renal failure.
Clinical Pharmacology and Therapeutics.
45:321-327.
1989
|
|
| 1989
|
Poles apart. A Forefront Symposium on the Organization of Membrane Polarity in Epithelial Cells sponsored by the International Society of Nephrology, the Swiss National Science Fund, and the 450th Anniversary Fund of the University of Lausanne, Arolla, Switzerland, July 2-6, 1989..
The New biologist.
1:149-151.
1989
|
|
| 1988
|
Adrenocortical function in the acquired immunodeficiency syndrome (AIDS).
The Western journal of medicine.
148:70-73.
1988
|
|
| 1988
|
Idiopathic pulmonary fibrosis.
The Western journal of medicine.
149:199-203.
1988
|
|
| 1988
|
Interactions of chloride and amiloride with the renal Na+/H+ antiporter.
Journal of Biological Chemistry.
263:7216-7221.
1988
|
|
| 1988
|
Pheochromocytoma - Recent advances in diagnosis and treatment.
The Western journal of medicine.
148:561-567.
1988
|
|
| 1988
|
The clinical significance of water pollution.
The Western journal of medicine.
148:192-196.
1988
|
|
| 1988
|
Uremic acidosis.
Kidney International.
34:278-287.
1988
|
|
| 1987
|
Advances in the prenatal diagnosis of sickle cell anemia.
The Western journal of medicine.
147:580-583.
1987
|
|
| 1987
|
The effects of cycloheximide on Na+/H+ antiporter activity in cultured opossum kidney cells
1987
|
|
| 1987
|
Activation of ion transport systems during cell volume regulation
1987
|
|
| 1987
|
Acute pancreatitis.
The Western journal of medicine.
146:598-602.
1987
|
|
| 1987
|
Biochemical and clinical aspects of amyloidosis.
The Western journal of medicine.
147:65-70.
1987
|
|
| 1987
|
Current concepts in the treatment of tuberculosis.
The Western journal of medicine.
146:461-465.
1987
|
|
| 1987
|
K-C1 transport systems in rabbit renal basolateral membrane vesicles.
American Journal of Physiology.
252.
1987
|
|
| 1987
|
K-C1 transport systems in rabbit renal basolateral membrane vesicles
1987
|
|
| 1987
|
N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, amiloride analogues, and renal Na+/H+ antiporter
1987
|
|
| 1987
|
New approaches to treating systemic lupus erythematosus.
The Western journal of medicine.
147:181-186.
1987
|
|
| 1987
|
Parallel adaptation of the rabbit renal cortical sodium/proton antiporter and sodium/bicarbonate cotransporter in metabolic acidosis and alkalosis..
Journal of Clinical Investigation.
80:308-315.
1987
|
|
| 1986
|
Downwind update - a discourse on matters gaseous.
The Western journal of medicine.
145:502-505.
1986
|
|
| 1986
|
Atrial natriuretic factor.
The Western journal of medicine.
144:591-596.
1986
|
|
| 1986
|
Electrically neutral Na+-H+ exchange in endosomes obtained from rabbit renal cortex
1986
|
|
| 1986
|
Electrogenic sodium/bicarbonate cotransport in rabbit renal cortical basolateral membrane vesicles.
Journal of Clinical Investigation.
78:1472-1478.
1986
|
|
| 1986
|
Exercise and coronary artery disease - what should we be recommending to our patients (and ourselves)?.
The Western journal of medicine.
144:205-211.
1986
|
|
| 1986
|
Parathyroid hormone inhibition of Na+-H+ antiporter activity in a cultured renal cell line
1986
|
|
| 1986
|
The effects of nicardipine in hypertensive subjects with impaired renal function.
British Journal of Clinical Pharmacology.
22.
1986
|
|
| 1986
|
The pathogenesis and prevention of diabetic nephropathy.
The Western journal of medicine.
145:222-227.
1986
|
|
| 1985
|
Primary hepatocellular carcinoma - Recent advances and future prospects.
The Western journal of medicine.
143:503-507.
1985
|
|
| 1985
|
Biologic Regulation of Na/H Antiporter Activity in a Cultured Kidney Cell Line: Effects of Parathyroid Hormone (PTH).
Annals of the New York Academy of Sciences.
456:451-453.
1985
|
|
| 1985
|
Diagnosis and management of lower gastrointestinal tract hemorrhage.
The Western journal of medicine.
143:80-87.
1985
|
|
| 1985
|
Effects of carboxyl activation by ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ) on the Na/H antiporter in rabbit renal brush border membrane vesicles (BBMV)
1985
|
|
| 1985
|
KCl countertransport in rabbit renal cortical basolateral membrane vesicles
1985
|
|
| 1985
|
Regulation of the Activity of the Na+‐H+ Antiporter in Brush‐Border Membrane Vesicles from the Proximal Tubule.
Annals of the New York Academy of Sciences.
456:229-231.
1985
|
|
| 1985
|
Stress and medical training.
The Western journal of medicine.
142:814-819.
1985
|
|
| 1985
|
Therapeutic strategies in congestive heart failure and the new inotrope-vasodilator agents.
The Western journal of medicine.
142:235-244.
1985
|
|
| 1984
|
Hyperkalemia.
The Western journal of medicine.
141:666-671.
1984
|
|
| 1984
|
Ion transport processes in apical membranes of epithelia
1984
|
|
| 1984
|
Increased V(max) for Na+/H+ antiporter activity in proximal tubule brush border vesicles from rabbits with metabolic acidosis.
American Journal of Physiology.
16.
1984
|
|
| 1984
|
Na-Cl cotransport in the renal medullary thick ascending limb of Henle's loop (TALH): Lack of potassium stimulation
1984
|
|
| 1984
|
Na+/H+ antiporter in membrane populations resolved from a renal brush border vesicle preparation.
American Journal of Physiology.
15.
1984
|
|
| 1984
|
Na+/H+ antiporter in membrane populations resolved from a renal brush border vesicle preparation
1984
|
|
| 1984
|
Paget's disease of bone.
The Western journal of medicine.
140:763-768.
1984
|
|
| 1984
|
Problems in diagnosing pneumonia.
The Western journal of medicine.
140:594-601.
1984
|
|
| 1984
|
The design of rational combination chemotherapy for cancer.
The Western journal of medicine.
140:921-928.
1984
|
|
| 1983
|
Hypoglycemia: A pitfall of insulin therapy.
The Western journal of medicine.
139:688-695.
1983
|
|
| 1983
|
Liver transplantation.
The Western journal of medicine.
139:507-514.
1983
|
|
| 1983
|
Familial colonic cancer syndromes.
The Western journal of medicine.
139:351-359.
1983
|
|
| 1983
|
Asymmetrical distributions of the Na+/H+ antiporter in the renal proximal tubule epithelial cell.
Journal of Biological Chemistry.
258:13513-13516.
1983
|
|
| 1983
|
Effects of chloride gradients on total CO2 flux in the rabbit cortical collecting tubule.
American Journal of Physiology.
13.
1983
|
|
| 1983
|
Effects of chloride gradients on total CO2 flux in the rabbit cortical collecting tubule
1983
|
|
| 1983
|
Mixed type inhibition of the renal Na+/H+ antiporter by the Li+ and amiloride. Evidence for a modifier site.
Journal of Biological Chemistry.
258:9710-9716.
1983
|
|
| 1983
|
Osteoporosis. Part II. Prevention of bone loss and fractures in women and risks of menopausal estrogen therapy.
The Western journal of medicine.
139:204-211.
1983
|
|
| 1983
|
Pemphigus.
The Western journal of medicine.
138:699-705.
1983
|
|
| 1983
|
Use of diuretics in the treatment of cirrhotic ascites.
Gastroenterology.
84:1051-1055.
1983
|
|
| 1982
|
Sodium uptake mechanisms in brush-border membrane vesicles prepared from rabbit renal cortex
1982
|
|
| 1982
|
Acidification in the in vitro perfused tubule.
Kidney International.
22:507-518.
1982
|
|
| 1982
|
Anion permeabilities of the isolated perfused rabbit proximal tubule.
American Journal of Physiology.
11.
1982
|
|
| 1982
|
Anion permeabilities of the isolated perfused rabbit proximal tubule
1982
|
|
| 1982
|
Na+/H+ antiporter of brush border vesicles: Studies with acridine orange uptake.
American Journal of Physiology.
11.
1982
|
|
| 1982
|
Na+/H+ antiporter of brush border vesicles: Studies with acridine orange uptake
1982
|
|
| 1982
|
NaCl entry mechanisms in the luminal membrane of the renal tubule.
American Journal of Physiology.
11.
1982
|
|
| 1982
|
NaCl entry mechanisms in the luminal membrane of the renal tubule
1982
|
|
| 1981
|
Proton gradients in renal cortex brush-border membrane vesicles. Demonstration of a rheogenic proton flux with acridine orange..
Journal of Biological Chemistry.
256:11663-11666.
1981
|
|
| 1981
|
Chloride uptake by brush border membrane vesicles isolated from rabbit renal cortex. Coupling to proton gradients and K+ diffusion potentials.
Journal of Clinical Investigation.
67:103-115.
1981
|
|
| 1981
|
Effects of chloride (C1) gradients on total CO2 flux in cortical collecting tubules (CCTS).
Clinical research.
29.
1981
|
|
| 1979
|
Effect of acetazolamide on bicarbonate reabsorption in the proximal tubule of the rat
1979
|
|
| 1979
|
Treatment of Hyperuricemia and Gout.
New England Journal of Medicine.
301:1240-1241.
1979
|
|
| 1979
|
Carbonic anhydrase-dependent bicarbonate reabsorption in the rat proximal tubule
1979
|
|
| 1979
|
Carbonic anhydrase-dependent bicarbonate reabsorption in the rat proximal tubule..
American Journal of Physiology.
236.
1979
|
|
| 1979
|
Effect of acetazolamide on bicarbonate reabsorption in the proximal tubule of the rat.
American Journal of Physiology.
6.
1979
|
|
| 1979
|
Effects of anion-transport inhibitors on NaCl reabsorption in the rat superficial proximal convoluted tubule.
Journal of Clinical Investigation.
64:570-579.
1979
|
|
| 1979
|
Proton secretion by the kidney..
Annual Review of Physiology.
41:197-210.
1979
|
|
| 1978
|
Contribution of leaked load to solute transport by renal tubules..
American Journal of Physiology.
234.
1978
|
|
| 1978
|
Contribution of leaked load to solute transport by renal tubules
1978
|
|
| 1978
|
Effects of acetazolamide (ACTZ) on total CO2 reabsorption in the rat.
Kidney International.
14:753.
1978
|
|
| 1978
|
Ion selectivity and proximal salt reabsorption.
American Journal of Physiology.
4.
1978
|
|
| 1978
|
Ion selectivity and proximal salt reabsorption
1978
|
|
| 1978
|
Luminal furosemide inhibits NaCl reabsorption in the superficial proximal tubule.
Clinical research.
26.
1978
|
|
| 1978
|
Occupancy of aldosterone binding sites in rat kidney cytosol.
Molecular and Cellular Endocrinology.
12:221-233.
1978
|
|
| 1977
|
Dual effects of diuretics on volume reabsorption by the proximal tubule.
Kidney International.
12:566.
1977
|
|
| 1977
|
Urinary acidification: CO2 transport by the rabbit proximal straight tubule.
American Journal of Physiology.
232.
1977
|
|
| 1975
|
Measurement of Picomole Amounts of Carbon Dioxide by Calorimetry.
Analytical Chemistry.
47:765-767.
1975
|
|
| 1975
|
Spirolactone binding by aldosterone receptors in rat kidney cytosol.
Clinical research.
23.
1975
|
|
